ALINT.PA IntegraGen down 27.72% intraday on EURONEXT 18 Feb 2026: risk to watch

ALINT.PA stock plunged -27.72% intraday on 18 Feb 2026, trading at €0.13 on EURONEXT during the European session. The sharp move follows heavy selling from the open at €0.17 and a previous close of €0.184, with volume at 37,171 shares versus a 30-day average of 15,796. We focus on why IntegraGen SA (ALINT.PA) moved sharply lower today, how its financials and technicals support the drop, and what traders should watch next in this intraday top losers setup.

ALINT.PA stock: Intraday price action and drivers

The intraday decline left ALINT.PA at €0.13, a €0.051 fall from the previous close, with a day low of €0.13 and day high of €0.1705. Volume spiked to 37,171, more than double the average daily volume of 15,796, signalling outsized selling pressure. There is no single public company release tied to the drop; market participants cited comparative sector screens and peer volatility source. Traders reacted in the low-liquidity micro-cap environment of EURONEXT, Europe, amplifying moves.

ALINT.PA stock: Financials and valuation snapshot

IntegraGen SA shows weak profitability and tight liquidity: EPS -0.04, reported PE -4.25, and market cap €1,123,155.00 on EURONEXT. Revenue per share is €1.01 while net income per share is -€0.23, underlining negative earnings. Balance sheet metrics include cash per share €0.26, debt-to-equity 1.23, and current ratio 1.19. Price-to-sales is 0.17 and price-to-book is 3.32, reflecting low revenue valuation but limited shareholder equity coverage.

ALINT.PA stock: Technicals and trading signals

Short-term technicals show mixed momentum: RSI 56.33, MACD 0.01, and ADX 27.33 indicating a strong intraday trend. The 50-day average is €0.15 and the 200-day average is €0.26, with Bollinger upper band at €0.19 and lower band €0.13. Near-term support sits around the year low €0.115 and psychological levels at €0.12; immediate resistance is the previous close €0.184 and the Bollinger upper €0.19. Traders should watch order book depth in this low-cap stock for slippage risk.

ALINT.PA stock: Meyka AI grade and forecast model

Meyka AI rates ALINT.PA with a score out of 100: 61.46 (Grade B) — HOLD. This grade factors S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are informational and not investment advice. Meyka AI’s forecast model projects monthly €0.13 and quarterly €0.01 versus the current price €0.133. That implies a short-term change of -2.26% to the monthly forecast and -92.48% to the quarterly forecast. Forecasts are model-based projections and not guarantees.

ALINT.PA stock: Risks, catalysts and sector context

Key risks include low liquidity, micro-cap volatility, negative earnings, and debt-to-equity 1.23, which amplify downside in stressed sessions. IntegraGen is a subsidiary of OncoDNA and operates in Healthcare/Biotechnology, a sector that shows modest recent performance in Europe. Potential catalysts are renewed contract wins in genomic services, clinical sequencing announcements, or parent-level strategic moves. No major company-specific releases were listed today; peer screens and sector comparisons may have driven relative repositioning source.

Final Thoughts

ALINT.PA stock finished the intraday session at €0.13 on EURONEXT after a -27.72% move on 18 Feb 2026. The drop combined higher-than-normal volume (37,171 shares) with weak fundamentals: negative EPS -€0.04, PE -4.25, and limited market cap €1,123,155.00. Technicals show short-term support near €0.12 and resistance near €0.19, with the 50-day average at €0.15. Meyka AI’s scenario-based targets: a near-term base target €0.12, a bull 12-month target €0.30, and a bear target €0.05, reflecting low liquidity and execution risk. Meyka AI’s forecast model projects monthly €0.13 and quarterly €0.01; these are model projections and not guarantees. Traders should treat ALINT.PA as a high-risk micro-cap and monitor EURONEXT order-book depth, upcoming corporate updates, and sector flows before sizing positions. For a quick view, see the ALINT.PA page on Meyka for live data and tools: ALINT.PA on Meyka.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.